Abstract: Previous studies have suggested that high-fat diets adversely affect bone development. However, these studies included other dietary manipulations, including low calcium, folic acid, and fibre, and (or) high sucrose or cholesterol, and did not directly compare several common sources of dietary fat. Thus, the overall objective of this study was to investigate the effect of high-fat diets that differ in fat quality, representing diets high in saturated fatty acids (SFA), n-3 polyunsaturated fatty acids (PUFA), or n-6 PUFA, on femur bone mineral density (BMD), strength, and fatty acid composition. Forty-day-old male Sprague-Dawley rats were maintained for 65 days on high-fat diets (20% by weight), containing coconut oil (SFA; n = 10), flaxseed oil (n-3 PUFA; n = 10), or safflower oil (n-6 PUFA; n = 11). Chow-fed rats (n = 10), at 105 days of age, were included to represent animals on a control diet. Rats fed high-fat diets had higher body weights than the chow-fed rats (p < 0.001). Among all high-fat groups, there were no differences in femur BMD (p > 0.05) or biomechanical strength properties (p > 0.05). Femurs of groups fed either the high n-3 or high n-6 PUFA diets were stronger (as measured by peak load) than those of the chow-fed group, after adjustment for significant differences in body weight (p = 0.001). As expected, the femur fatty acid profile reflected the fatty acid composition of the diet consumed. These results suggest that high-fat diets, containing high levels of PUFA in the form of flaxseed or safflower oil, have a positive effect on bone strength when fed to male rats 6 to 15 weeks of age.
Introduction
It is well known that bone development is highly dependent on the status of nutrients, such as vitamin D and calcium. Past rodent research has suggested that, in combination with low vitamin D and calcium, high dietary fat (18%-24% by weight) impairs bone development (Li et al. 1990; Salem et al. 1992; Zernicke et al. 1995; Parhami et al. 2001; Ward et al. 2003; Lac et al. 2008; Cao et al. 2009 ). Specifically, femoral (Zernicke et al. 1995; Parhami et al. 2001; Ward et al. 2003) , tibial (Li et al. 1990; Cao et al. 2009 ), and vertebral (Salem et al. 1992; Zernicke et al. 1995; Parhami et al. 2001 ) bone mineral content (BMC) and density (BMD) were lower after 10 weeks to 20 months of high-fat feeding. High-fat diets, in combination with other dietary manipulations, over short-and long-term feeding regimes, significantly affect both bone quantity and quality.
Despite the seemingly consistent findings that high-fat diets have negative effects on bone health, many of the aforementioned studies manipulated other dietary factors, including lower levels of calcium, folic acid, and fibre , and high levels of sucrose (Li et al. 1990; Salem et al. 1992 ) and cholesterol (Parhami et al. 2001) . Given these dietary confounders, it is challenging to isolate the sole effect of consuming high-fat diets.
In addition to the quantity of fat in the diet and the potential influence of nutritional confounders, the quality or type of dietary fat, such as saturated fatty acids (SFA), n-3 polyunsaturated fatty acids (PUFA), and n-6 PUFA, may also be an important determinant of health outcomes (Hu et al. 2001) . Previous research has suggested that dietary supplementation of flaxseed oil, rich in a-linolenic acid (ALA), the essential n-3 PUFA, appears to be more beneficial toward improvements in BMC and BMD (Korotkova et al. 2004 ). However, these findings are limited to diets with normal levels of fat (7% by weight), and focused on ALA (Korotkova et al. 2004; Weiler et al. 2007) . No studies have specifically compared the effects of high-fat diets (20% by weight) rich in ALA, linoleic acid, or SFA on BMD and biomechanical bone strength.
Findings from bone cell culture studies have shown that specific key mediators of the bone microenvironment, including osteoprotegrin, receptor activator of nuclear factor-kb ligand, prostaglandin E 2 (PGE 2 ), and cyclooxygenase-2, can be modulated by changes in type of fatty acids present, and thus provide a mechanism for the positive effects of n-3 PUFA on BMD Coetzee et al. 2007 ). Specifically, the addition of n-3 PUFA to bone cell media has been shown to modulate cyclooxygenase-2 protein expression, reduce PGE 2 production, and increase alkaline phosphatase activity . Combining these findings with the fact that the fatty acid composition of bone tissue reflects the dietary fatty acid composition (Alam et al. 1993; Li et al. 2003; Sacco et al. 2009 ) provides evidence that it is biologically plausible for changes in the fatty acid composition of bone to alter the bone microenvironment and influence BMD and bone strength. Given that the ratio of cortical and trabecular bone differs markedly throughout the femur, and that trabecular bone has a faster turnover rate (Downey and Siegel 2006) , we hypothesize that the distribution of fatty acids and, in turn, bone outcomes differ by femur region. Moreover, a previous study has shown that differences in the composition of dietary lipids reflect the fatty acid distribution in ovariectomized rat femur compartments, namely the periosteum, cortical bone, trabecular bone, and marrow (Watkins et al. 2006) . However, as that study manipulated PUFA levels in diets, with 25% energy derived from fat (Watkins et al. 2006) , the effects of high-fat diets with different compositions on the fatty acid profile of various bone compartments have not been investigated in a healthy rodent model at young adulthood.
To our knowledge, there is a shortage of studies examining the influence of a high-fat diet of varying quality on bone strength and BMD. Based on the studies highlighted earlier, we hypothesize that the high-fat diet containing n-3 PUFA will have a favourable effect on bone outcomes. Thus, the aims of this study were to investigate the effect of 65 days of a high-fat diet on femur BMD, strength, and fatty acid composition in male rats in early adulthood, and to determine if the effects on bone differ among rats fed different compositions of fat (SFA, n-3 PUFA, or n-6 PUFA).
Materials and methods

Animals and diets
Forty-day-old male Sprague-Dawley rats (Charles River Laboratories, Saint-Constant, Que.) were housed in standard environmental conditions, with a 12 h light : 12 h dark cycle and ad libitum access to water and their assigned diet: an 18% coconut oil and 2% soybean oil diet (% by weight) (no. TD.08023; Harlan Teklad, Madison, Wis.) for the SFA group (n = 10); a 20% flaxseed oil diet (% by weight) (no. TD.07777; Harlan Teklad) for the n-3 PUFA group (n = 10); or a 20% safflower oil diet (% by weight) (no. TD.07776; Harlan Teklad) for the n-6 PUFA group (n = 11). All other diet ingredients were the same, apart from the oil source (Table 1) . Fatty acid composition (percent mole fraction >1%) of the high-fat diets was analyzed (Table 2) . Ten male, chow-fed (5.2% by weight porcine lard-fish mealsoybean oil; Purina 5L79, Charles River Laboratories) rats, at 105 days of age, were included in the study as a control. Food consumption and body weights were measured daily when food was replenished. On day 65 of treatment, all rats were anaesthetized with an intraperitoneal injection of sodium pentobarbital (6 mgÁ100 g -1 body weight), final body weights were measured using an electronic scale, and femurs were excised, cleaned of soft tissue, and stored at -80 8C until analysis. The study and all protocols and procedures were approved by the Brock University (St. Catharines, Ont.) Animal Care and Utilization Committee, and conformed to the guidelines of the Canadian Council on Animal Care (1993).
Femur dimensions and biomechanical strength testing
Three-point bending was performed at femur midpoint, using a materials testing system (Model 4442, Instron Corp., Canton, Mass.), to determine the elastic and plastic properties contributing to bone strength (yield load, resilience, stiffness, peak load, and toughness) at a site rich in cortical bone, as described elsewhere (Breitman et al. 2003) . Femurs were soaked in physiological saline (9 g NaClÁL -1 ) for 4 h at room temperature prior to testing, and were subsequently weighed using an electronic scale. Femur length, width, and depth were measured using electronic precision calipers. Length was measured from the proximal tip of the femur head to distal tip of the medial condyle. The mediolateral (width) and anteroposterior (depth) dimensions were measured at the midpoint of the femur diaphysis, as femurs are not true cylinders. For 3-point bending, the posterior surface of the femur was placed on 2 supporting bars of a bending jig, which were positioned 15 mm apart, on the materials testing system. The crosshead was lowered at a constant rate of 2 mmÁmin -1 . The displacement of the crosshead (in mm) and the force exerted on the bone (in N) were recorded on a load displacement curve, using a specialized software program (Instron Series IX Automated Materials Tester, version 8.15.00, Instron Corp.).
Femur BMD and BMC
BMC and bone area of the left femurs were measured with dual energy X-ray absorptiometry (pDEXA Sabre, Model 932937, Stratec Medizintechnik GmbH, Germany), using a specialized software program (host software version 3.9.4; scanner software version 1.2.0), which calculated BMD. Scans were conducted at a speed of 10 mmÁs -1 and a resolution of 0.5 Â 0.5 mm. The coefficients of variation were 0.89% and 0.67% for BMD and BMC, respectively.
Femur lipid analyses
Right femurs were transversely cut into 3 segments, using a band saw according to anatomical points, to approximate locations comprised mainly of trabecular bone (epiphysis) or cortical bone (diaphysis). The proximal epiphyseal region (containing mainly trabecular bone) was segmented with a diagonal cut from the greater trochanter to the lesser trochanter. The distal epiphyseal region, also containing mainly trabecular bone, was approximated by cutting at a point above the nutrient foramen. The remaining segment was considered the diaphysis, which contains mainly cortical bone. Bone marrow was flushed out of each respective segment using 1.5 mL of saline solution (0.9%). The 3 sections were individually wrapped in aluminum foil, submersed in liquid nitrogen, and then hammered and pulverized with a mortar and pestle, as described elsewhere (Sacco et al. 2009 ). The powder was transferred to 50 mL glass screw caps, and total lipids were extracted with 2:1 chloroform:methanol (Folch et al. 1957) . Extracted lipids were dried under gentle nitrogen, and subsequently reconstituted in 2 mL of chloroform to form the lipid stock.
Total lipid from each sample was saponified and methylated, as described elsewhere (Sacco et al. 2009 ). Briefly, 2 mL of KOH (0.5 molÁL -1 ) in methanol was added to 0.2 to 2.0 mL of lipid stock, and was allowed to saponify at 100 8C for 1 h. For hexane and 6% H 2 SO 4 -MeOH, 2 mL each was added and allowed to methylate at 100 8C for 1 h. Double-distilled water was added, and samples were vortexed and phase separated at 1460 rÁmin -1 for 10 min. The hexane layer was placed into a gas chromatography (GC) vial, dried down under nitrogen, and reconstituted in 0.1 mL of hexane for GC analysis, as described elsewhere (Bradley et al. 2008 ). Briefly, a 2 mL sample of fatty acid methyl esters from each sample was injected into a GC (Trace GC Ultra, Thermo Electron Corp, Milan, Italy) fitted with a split-splitless injector, a fast flame ionization detector, and Triplus AS autosampler (TraceGC Ultra, Thermo Electron Corp). Fatty acid methyl esters were separated on an UFM RTX-WAX analytical column (Thermo Electron Corp.), using helium as a carrier gas. Fatty acids were identified by comparing retention times with those of a known standard (Supelco 37 component FAME mix, Supelco, Bellefonte, Pa.), and absolute amounts of individual fatty acids were calculated with the aid of the internal standard, tridecanoic acid (13:0), added to the samples before the methylation process. Prior to the analysis of sample, there were no detectable endogenous 13:0 in the samples (data not shown).
Statistical analyses
Results are expressed as means ± SE. Statistical analyses were performed using PASW Statistics (version 17.0.2, SPSS Inc., Chicago, Ill.). For body weight, diet consumption, fat pad weight, and bone fatty acids, 1-way analysis of variance (ANOVA) was used to determine differences among groups. When the p value was less than 0.05, the Student-Newman-Keuls multiple comparisons test was conducted. For all bone measurements, analysis of covariance (ANCOVA) was applied to reveal any differences between groups after adjustment for final body weight, followed by the Sidak multiple comparisons test.
Results
Body morphometrics and diet consumption
The SFA group significantly weighed more than the n-3 PUFA and chow group at necropsy (p < 0.001), and consumed more energy than either PUFA group (Table 3) . The final body weight of the n-6 PUFA group was also greater than the chow group. The SFA group had higher epididymal, retroperitoneal, and omental fat pad weights than the n-3 PUFA group and the chow group (p < 0.001). Greater epididymal fat pad weight was also observed in the SFA group, compared with the n-6 PUFA group (p < 0.001). A similar pattern emerged when the sum of the fat pads was analyzed. The SFA group had a higher total fat pad weight than the n-3 PUFA group and the chow group (p < 0.001). The final body weight, fat pad weights, and the sum of those fat pads in the chow group were the lowest among all groups (p < 0.001).
Dimensions and biomechanical strength properties at femur midpoint
Femur weight and dimensions were lower in the chow group than in all other groups, with or without adjustment for body weight, except for the adjusted femur length, which did not vary among groups, and adjusted femur width, which was higher in the n-3 PUFA group than in the chow Note: Values are expressed as means ± SE. For final body weight, n = 10 for the SFA group; n = 10 for the n-3 PUFA; n = 11 for the n-6 PUFA group; n = 10 for the chow group. For fat pad weights, n = 9 for the SFA group; n = 9 for the n-3 PUFA group; n = 10 for the n-6 PUFA group; n = 10 for the chow group. Within a row, statistically different values are marked with different letters, p < 0.05. SFA, saturated fatty acid; PUFA, polyunsaturated fatty acid; nm, not measured. group (p = 0.011) ( Table 4) . Unadjusted values for yield load, resilience, stiffness, peak load, and toughness were greater in the 3 high-fat groups than in the chow group (p < 0.001). After adjustment for body weight, stiffness (p = 0.005) and peak load (p = 0.001) were higher in the n-3 and n-6 PUFA groups than in the chow group, with no differences between the SFA group and the other 3 groups.
Femur BMD and BMC
Whole femur BMD (p = 0.010) and BMC (p = 0.004) were lower in the chow group than in the other groups before adjustment for body weight (Table 4) . After adjustment, there were no significant differences among groups.
Femur lipid composition
Percent mole fraction of predominate fatty acids are presented for bone marrow (Table 5) , diaphysis (Table 6) , proximal epiphysis (Table 7) , and distal epiphysis (Table 8) of femurs. Fatty acids less than 1% (15:0, 17:0, 20:0, 22:0, 23:0, 14:1, 15:1, 17:1, 22:1, 24:1, 20:5n-3, 22:6n-3, 18:3n-6, 20:2n-6, 20:3n-6, 20:4n-6, and 22:2n-6) are not presented in the tables. All 4 sites responded to dietary fat sources, demonstrating fatty acid profiles similar to their respective diets. From all 4 samples analyzed, the n-3 PUFA group had greater (p < 0.05) levels of total n-3 PUFA, which were predominately ALA, than all other groups. The longchain n-3 PUFA eicosapentaenoic acid (EPA; 20:5n-3) and Note: All data are expressed as means ± SE. All measurements were adjusted for final body weight and are presented with unadjusted values for comparison. Within a row, statistically different values are marked with different letters, p < 0.05. SFA, saturated fatty acid; PUFA, polyunsaturated fatty acid; BMD, bone mineral density; BMC, bone mineral content.
*Depth refers to the anteroposterior width at femur midpoint.
{
Width refers to the mediolateral width at femur midpoint.
docosahexaenoic acid (22:6n-3) were not different among groups in any of the sites (data not shown). Similarly, the n-6 PUFA group had greater (p < 0.05) levels of total n-6 PUFA, which were predominately linoleic acid, than other groups at all 4 sites. The long-chain n-6 PUFA arachidonic acid (20:4n-6) was not different among groups at any of the sites (data not shown). The SFA group had the greatest level of SFA at all sites, compared with other groups, with lauric (12:0) and myristic (14:0) acids being the main contributors.
Discussion
Our findings demonstrate that rats fed high-fat diets, regardless of their dietary fat source, had greater femoral size, strength, BMD, and BMC than the chow-fed rats. As bone turnover and density are influenced by body weight (Reid 2002) , the markedly higher body weight among rats fed high-fat diets may have contributed to the greater femur yield load, resilience, toughness, BMC, and BMD. However, after adjustment for differences in final body weight, differences in femur weight and depth persisted, with the SFA, n-3 PUFA, and n-6 PUFA groups being significantly higher than the chow group. Adjustment for differences in final body weight also showed that the n-3 PUFA and n-6 PUFA groups had higher peak load and stiffness than the chow group, while the SFA group was intermediary. This finding, in particular, may suggest potential benefits of high levels of dietary PUFA on bone strength.
The higher final body weights among all the groups receiving a high-fat diet are consistent with other studies (Levin and Keesey 1998; Ghibaudi et al. 2002) . In addition, the observation of lower body weight and fat pad weights in the high-fat n-3 PUFA group, compared with the high-fat SFA group, is supported by other studies showing that consumption of n-3 PUFA reduces weight gain, which may be mediated through lower food consumption (Hassanali et al. 2010) . While saturated fat is commonly regarded as adipogenic (Su and Jones 1993) , the medium-chain and cholesterol-free coconut oil may be more easily oxidized than the long-chain cholesterol-containing beef tallow (Papamandjaris et al. 2000; Moussavi et al. 2008 ), leading to adiposity that is a relatively similar to that in n-6 PUFA diets. Despite these potential differences in metabolic handling, the SFA group did have the highest body weight and fat pad masses, due in part to higher energy consumption, compared with the n-3 PUFA group. In fact, body weight gain per unit of energy consumed was similar across all high-fat groups, suggesting that the amount of fat, rather than the composition, may affect energy consumption and, in turn, weight gain.
Saturated fat is typically regarded as a promoter of bone resorption and an inhibitor of bone formation through several mechanisms, including reduction of calcium uptake and inhibition of osteogenic differentiation (Atteh and Leeson 1984; Wohl et al. 1998) . In comparison to the n-3 and n-6 PUFA groups, our results did not indicate poorer bone quality after 65 days of a high-SFA diet. Because previous literature examining the effects of high-SFA diets have focused on an avian model of bone metabolism and used long-chain SFA with cholesterol as a dietary modulator (Atteh and Leeson 1984; Wohl et al. 1998) , our use of coconut oil with mediumchain fatty acids may have had less of an impact on bone turnover. This possibility warrants further investigation to establish if this effect is due to fatty acid chain length and (or) cholesterol content. Moreover, differences in the species and age of the animals studied may have resulted in the dissimilar effects.
Our study demonstrated that n-3 and n-6 PUFA-enriched diets had similar effects on the biomechanical strength and BMD of femurs, despite the fatty acid compositions of bone marrow and 3 femur regions reflecting the dietary fatty acid content in both high-fat groups. Both ALA and linoleic acid, Table 7 . Percent mole fraction of fatty acids extracted from femur proximal epiphysis from rats fed chow or different high-fat diets. prominent in their respective n-3 and n-6 PUFA diets used in this study, are substrates for elongase and desaturase enzymes in the synthesis of long-chain, more unsaturated EPA and arachidonic acid, respectively (Burdge 2006) . Although both EPA and arachidonic acid are substrates for eicosanoid production, the products of n-6 PUFA (e.g., PGE 2 ) tend to exert inflammatory effects, and the products of n-3 PUFA (e.g., PGE 3 ) are anti-inflammatory. The inflammatory effects of PGE 2 and other inflammatory cytokines (e.g., tumor necrosis factor-a) have been used to explain the suppression of bone formation and the enhancement of bone resorption (Watkins et al. 1996 (Watkins et al. , 1997 , possibly through the upregulation of RANKL, an osteoclast activator (Hofbauer and Heufelder 2001) . In contrast, n-3 PUFA inhibit this process (Sun et al. 2003) and promote osteoblastogenesis in the bone marrow (Shen et al. 2008 ) and bone formation (Watkins et al. 1997 . However, the anti-inflammatory effects of n-3 PUFA were mostly demonstrated in studies that employed diets rich in EPA and docosahexaenoic acid (Lucia et al. 2003; Sun et al. 2003; Green et al. 2004; Bhattacharya et al. 2007) .
Given the extensive evidence linking flaxseed to health benefits (Adolphe et al. 2010) , ALA was specifically chosen for investigation in this study. Although investigations focusing on diets rich in ALA reported little or no difference from diets rich in n-6 PUFA (Watkins et al. 2000; Weiler and Fitzpatrick-Wong 2002) , these studies did not consider implementing high levels of dietary ALA to investigate skeletal health. The small or lack of effects of ALA diets, regardless of overall fat level, may be explained by studies on mammalian fatty acid metabolism that suggest that D6 desaturases are limited in the synthesis of longer-chain n-3 PUFA in vivo, leading to low endogenous levels of EPA and docosahexaenoic acid (Burdge 2006) . Indeed, our results support this theory, as negligible EPA and docosahexaenoic acid were observed in bone marrow and 3 femur regions.
Conclusion
Feeding 6-week-old male rats high-fat diets rich in coconut oil (SFA), flaxseed oil (ALA), or safflower oil (linoleic acid) for 65 days resulted in greater body weight and fat pad mass, and did not adversely modulate bone mineral levels or biomechanical strength properties. Heavier body weight may be related to higher levels of bone mineral and some measures of bone strength. The fact that peak load remained significantly higher in the high-fat groups, fed n-3 PUFA or n-6 PUFA rich-diets, than in the chow group after adjustment for final body weight suggests positive effects of PUFA in bone metabolism, irrespective of body weight. Further studies will pursue the mechanisms of how these fatty acids mediate the effects on bone strength in the context of a high-fat diet.
